Robert J. Shovlin - 25 May 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Reporting relationship: President, Clinical Services
Issuer ticker: NEO
Reported as of: 25 May 2021
Net transaction value: -$3,635,514
SEC form: 4
Accepted by SEC: 27 May 2021, 18:23:32 UTC
Source filing: View source filing
Reporting owner signature: /s/ Robert J. Shovlin

Key filing fact

Robert J. Shovlin filed Form 4 for NEOGENOMICS INC (NEO) on 27 May 2021.

Key facts

This page summarizes Robert J. Shovlin's Form 4 filing for NEOGENOMICS INC (NEO).
7 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 27 May 2021, 18:23.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$3,635,514.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEO transaction

Common Stock

Options Exercise

Transaction value: $772,221
Shares: +96,167
Change %: +63%
Price: $8.03
Shares after: 249,914
Date: 25 May 2021
Ownership: Direct

NEO transaction

Common Stock

Options Exercise

Transaction value: $327,790
Shares: +16,724
Change %: +6.7%
Price: $19.60
Shares after: 266,638
Date: 25 May 2021
Ownership: Direct

NEO transaction

Common Stock

Options Exercise

Transaction value: $398,518
Shares: +14,067
Change %: +5.3%
Price: $28.33
Shares after: 280,705
Date: 25 May 2021
Ownership: Direct

NEO transaction

Common Stock

Sale

Transaction value: $5,134,043
Shares: -130,604
Change %: -47%
Price: $39.31
Shares after: 150,101
Date: 25 May 2021
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEO transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -96,167
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 25 May 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 96,167
Exercise price: $8.03
Footnotes: F2

NEO transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -16,724
Change %: -33%
Price: $0.000000
Shares after: 33,449
Date: 25 May 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,724
Exercise price: $19.60
Footnotes: F3

NEO transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -14,067
Change %: -25%
Price: $0.000000
Shares after: 42,204
Date: 25 May 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,067
Exercise price: $28.33
Footnotes: F4

NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 38,688
Date: 25 May 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 38,688
Exercise price: $53.17
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

On March 2, 2021, Mr. Shovlin was granted 38,688 stock options. These options vest ratably over the first four anniversary dates of the grant date

Footnote F2

On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.

Footnote F3

On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Footnote F4

On March 2, 2020, Mr. Shovlin was granted 56,271 stock options. These options vest ratably over the first four anniversary dates of the grant date.